Lucid Diagnostics (LUCD) Competitors $1.14 +0.06 (+5.05%) As of 10:53 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LUCD vs. KIDS, BFLY, TMCI, BBNX, NPCE, DCTH, SMLR, TCMD, CLPT, and CVRXShould you be buying Lucid Diagnostics stock or one of its competitors? The main competitors of Lucid Diagnostics include OrthoPediatrics (KIDS), Butterfly Network (BFLY), Treace Medical Concepts (TMCI), Beta Bionics (BBNX), NeuroPace (NPCE), Delcath Systems (DCTH), Semler Scientific (SMLR), Tactile Systems Technology (TCMD), ClearPoint Neuro (CLPT), and CVRx (CVRX). These companies are all part of the "medical equipment" industry. Lucid Diagnostics vs. OrthoPediatrics Butterfly Network Treace Medical Concepts Beta Bionics NeuroPace Delcath Systems Semler Scientific Tactile Systems Technology ClearPoint Neuro CVRx OrthoPediatrics (NASDAQ:KIDS) and Lucid Diagnostics (NASDAQ:LUCD) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, media sentiment, community ranking, profitability, earnings and institutional ownership. Which has more risk & volatility, KIDS or LUCD? OrthoPediatrics has a beta of 1.17, indicating that its share price is 17% more volatile than the S&P 500. Comparatively, Lucid Diagnostics has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500. Do analysts rate KIDS or LUCD? OrthoPediatrics currently has a consensus price target of $37.00, indicating a potential upside of 79.70%. Lucid Diagnostics has a consensus price target of $3.40, indicating a potential upside of 211.93%. Given Lucid Diagnostics' stronger consensus rating and higher possible upside, analysts clearly believe Lucid Diagnostics is more favorable than OrthoPediatrics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OrthoPediatrics 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80Lucid Diagnostics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 Is KIDS or LUCD more profitable? OrthoPediatrics has a net margin of -15.00% compared to Lucid Diagnostics' net margin of -1,069.87%. Lucid Diagnostics' return on equity of 0.00% beat OrthoPediatrics' return on equity.Company Net Margins Return on Equity Return on Assets OrthoPediatrics-15.00% -5.78% -4.80% Lucid Diagnostics -1,069.87%N/A -123.54% Does the media favor KIDS or LUCD? In the previous week, OrthoPediatrics had 2 more articles in the media than Lucid Diagnostics. MarketBeat recorded 9 mentions for OrthoPediatrics and 7 mentions for Lucid Diagnostics. OrthoPediatrics' average media sentiment score of 0.41 beat Lucid Diagnostics' score of 0.21 indicating that OrthoPediatrics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OrthoPediatrics 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Lucid Diagnostics 0 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals & insiders have more ownership in KIDS or LUCD? 69.1% of OrthoPediatrics shares are owned by institutional investors. Comparatively, 74.0% of Lucid Diagnostics shares are owned by institutional investors. 31.8% of OrthoPediatrics shares are owned by insiders. Comparatively, 8.8% of Lucid Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community favor KIDS or LUCD? OrthoPediatrics received 276 more outperform votes than Lucid Diagnostics when rated by MarketBeat users. However, 68.42% of users gave Lucid Diagnostics an outperform vote while only 64.42% of users gave OrthoPediatrics an outperform vote. CompanyUnderperformOutperformOrthoPediatricsOutperform Votes31564.42% Underperform Votes17435.58% Lucid DiagnosticsOutperform Votes3968.42% Underperform Votes1831.58% Which has preferable earnings & valuation, KIDS or LUCD? OrthoPediatrics has higher revenue and earnings than Lucid Diagnostics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Lucid Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOrthoPediatrics$204.73M2.44-$20.97M-$1.63-12.63Lucid Diagnostics$4.35M22.76-$52.67M-$1.08-1.01 SummaryLucid Diagnostics beats OrthoPediatrics on 10 of the 18 factors compared between the two stocks. Remove Ads Get Lucid Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for LUCD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LUCD vs. The Competition Export to ExcelMetricLucid DiagnosticsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$98.92M$4.08B$5.29B$7.35BDividend YieldN/A39.51%5.11%4.32%P/E Ratio-0.9627.7721.6917.68Price / Sales22.7649.01373.9692.89Price / CashN/A51.0838.1534.64Price / Book-2.325.836.363.94Net Income-$52.67M$67.64M$3.20B$247.45M7 Day Performance-12.80%2.89%3.96%3.17%1 Month Performance-25.85%-5.72%-10.34%-8.53%1 Year Performance35.89%12.86%10.38%0.32% Lucid Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LUCDLucid Diagnostics2.3494 of 5 stars$1.15+5.0%$3.40+196.9%+33.7%$103.01M$4.35M-1.0070Gap DownKIDSOrthoPediatrics4.3207 of 5 stars$21.80-4.0%$37.20+70.6%-31.8%$529.46M$204.73M-17.72200News CoverageHigh Trading VolumeBFLYButterfly Network2.465 of 5 stars$2.08+1.7%$3.00+44.6%+160.0%$504.07M$82.06M-4.51460News CoveragePositive NewsTMCITreace Medical Concepts2.8234 of 5 stars$7.61-1.8%$10.14+33.3%-43.5%$476.53M$209.36M-7.69250News CoverageBBNXBeta BionicsN/A$10.44+5.3%$24.83+137.9%N/A$452.56M$65.12M0.00294NPCENeuroPace3.0471 of 5 stars$12.30+0.6%$15.20+23.6%-25.7%$400.49M$79.91M-12.30170Short Interest ↑Gap DownDCTHDelcath Systems2.966 of 5 stars$10.91-0.9%$22.75+108.5%+144.2%$364.43M$37.21M-8.0860News CoveragePositive NewsGap DownSMLRSemler Scientific2.3299 of 5 stars$34.15+0.9%$71.00+107.9%+19.3%$327.74M$56.29M6.96120Short Interest ↑News CoverageTCMDTactile Systems Technology3.2431 of 5 stars$13.33+1.1%$18.00+35.0%-7.2%$315.47M$292.98M19.04980Positive NewsCLPTClearPoint Neuro2.0838 of 5 stars$10.95-0.7%$25.00+128.3%+106.5%$302.57M$31.39M-15.87110Gap UpCVRXCVRx1.9651 of 5 stars$11.54-1.5%$17.83+54.5%-62.5%$300.46M$51.29M-4.29160 Remove Ads Related Companies and Tools Related Companies KIDS Alternatives BFLY Alternatives TMCI Alternatives BBNX Alternatives NPCE Alternatives DCTH Alternatives SMLR Alternatives TCMD Alternatives CLPT Alternatives CVRX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LUCD) was last updated on 4/17/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lucid Diagnostics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lucid Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LUCD Stock Free LUCD Stock Alerts